Literature DB >> 15848761

Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.

Jin-Wook Kim1, Yong-Woo Kim, Yuichi Inagaki, You-A Hwang, Susumu Mitsutake, Yeon-Woo Ryu, Won Koo Lee, Hyun-Joon Ha, Chang-Seo Park, Yasuyuki Igarashi.   

Abstract

Sphingosine 1-phosphate (S1P), a product of sphingosine kinases (SphK), mediates diverse biological processes such as cell differentiation, proliferation, motility, and apoptosis. In an effort to search and identify specific inhibitors of human SphK, the inhibitory effects of synthetic sphingoid analogs on kinase activity were examined. Among the analogs tested, we found two, SG12 and SG14, that have specific inhibitory effects on hSphK2. N,N-Dimethylsphingosine (DMS), a well-known SphK inhibitor, displayed inhibitory effects for both SphK1 and SphK2, as well as protein kinase C. In contrast, SG12 and SG14 exhibited selective inhibitory effects on hSphK2. Furthermore, SG14 did not affect PKC. In isolated platelets, SG14 blocked the conversion of sphingosine into sphingosine 1-phosphate significantly. This is the first report on the identification of a hSphK2-specific inhibitor, which may provide a useful tool for studying the biological functions of hSphK2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15848761     DOI: 10.1016/j.bmc.2005.02.053

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  19 in total

1.  Design, synthesis and biological activity of sphingosine kinase 2 selective inhibitors.

Authors:  Mithun R Raje; Kenneth Knott; Yugesh Kharel; Philippe Bissel; Kevin R Lynch; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2011-11-15       Impact factor: 3.641

Review 2.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 3.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

4.  Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries.

Authors:  Salvatore Salomone; Guray Soydan; Peter Ching-Tze Ip; Kristen M Park Hopson; Christian Waeber
Journal:  Pharmacol Res       Date:  2010-09-17       Impact factor: 7.658

5.  Sphingolipid pathway regulates innate immune responses at the fetomaternal interface during pregnancy.

Authors:  Kiyomi Mizugishi; Takuya Inoue; Hiroshi Hatayama; Jacek Bielawski; Jason S Pierce; Yukiyasu Sato; Akifumi Takaori-Kondo; Ikuo Konishi; Kouhei Yamashita
Journal:  J Biol Chem       Date:  2014-12-11       Impact factor: 5.157

6.  The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.

Authors:  Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

7.  Methods for direct alkene diamination, new & old.

Authors:  Sam de Jong; Daniel G Nosal; Duncan J Wardrop
Journal:  Tetrahedron       Date:  2012-03-21       Impact factor: 2.457

Review 8.  A review of ceramide analogs as potential anticancer agents.

Authors:  Jiawang Liu; Barbara S Beckman; Maryam Foroozesh
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

Review 9.  Sphingosine 1-phosphate chemical biology.

Authors:  Kevin R Lynch; Timothy L Macdonald
Journal:  Biochim Biophys Acta       Date:  2008-06-25

10.  Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.

Authors:  Kai Liu; Tai L Guo; Nitai C Hait; Jeremy Allegood; Hardik I Parikh; Wenfang Xu; Glen E Kellogg; Steven Grant; Sarah Spiegel; Shijun Zhang
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.